BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1291 related articles for article (PubMed ID: 19740260)

  • 1. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between BODE index and systemic inflammatory biomarkers in COPD.
    Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
    COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
    Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
    Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
    Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
    Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD.
    Al-shair K; Dockry R; Mallia-Milanes B; Kolsum U; Singh D; Vestbo J
    Respir Med; 2009 Oct; 103(10):1572-9. PubMed ID: 19560330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients.
    Soler-Cataluña JJ; Martínez-García MA; Sánchez LS; Tordera MP; Sánchez PR
    Respir Med; 2009 May; 103(5):692-9. PubMed ID: 19131231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.
    Higashimoto Y; Iwata T; Okada M; Satoh H; Fukuda K; Tohda Y
    Respir Med; 2009 Aug; 103(8):1231-8. PubMed ID: 19249197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of BMI in patients with COPD.
    Karadag F; Karul AB; Cildag O; Altun C; Gurgey O
    Respirology; 2004 Mar; 9(1):70-5. PubMed ID: 14982605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index.
    Medinas Amorós M; Mas-Tous C; Renom-Sotorra F; Rubí-Ponseti M; Centeno-Flores MJ; Gorriz-Dolz MT
    Chron Respir Dis; 2009; 6(2):75-80. PubMed ID: 19411567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease.
    Ko FW; Lau CY; Leung TF; Wong GW; Lam CW; Hui DS
    Respir Med; 2006 Apr; 100(4):630-8. PubMed ID: 16213701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
    Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
    Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD.
    Liu SF; Wang CC; Chin CH; Chen YC; Lin MC
    Arch Bronconeumol; 2011 Sep; 47(9):427-32. PubMed ID: 21821335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
    Celli BR; Cote CG; Marin JM; Casanova C; Montes de Oca M; Mendez RA; Pinto Plata V; Cabral HJ
    N Engl J Med; 2004 Mar; 350(10):1005-12. PubMed ID: 14999112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs.
    Foglio K; Bianchi L; Bruletti G; Porta R; Vitacca M; Balbi B; Ambrosino N
    Respir Med; 2007 Sep; 101(9):1961-70. PubMed ID: 17531455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of erectile dysfunction in moderate-to-severe chronic obstructive pulmonary disease patients.
    Karadag F; Ozcan H; Karul AB; Ceylan E; Cildag O
    Respirology; 2007 Mar; 12(2):248-53. PubMed ID: 17298458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients.
    Yang YM; Sun TY; Liu XM
    Chin Med J (Engl); 2006 Apr; 119(8):628-33. PubMed ID: 16635406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The modified BODE index: validation with mortality in COPD.
    Cote CG; Pinto-Plata VM; Marin JM; Nekach H; Dordelly LJ; Celli BR
    Eur Respir J; 2008 Nov; 32(5):1269-74. PubMed ID: 18579541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of mortality in COPD.
    Celli BR
    Respir Med; 2010 Jun; 104(6):773-9. PubMed ID: 20417082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.